Preoperative chemotherapy in non-small-cell lung cancer: Nothing new in N2 disease

被引：1
|
作者：
De Pas, T [1 ]
Pastorino, U
Spaggiari, L
Curigliano, G
de Braud, F
Robertson, C
机构：
[1] European Inst Oncol, Milan, Italy
[2] Univ Strathclyde, Glasgow, Lanark, Scotland
[3] Scottish Ctr Infect & Environm Hlth, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 10期
关键词：
D O I：
10.1200/JCO.2002.20.10.2603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2603 / 2604
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non-Small-Cell Lung Cancer
    Liao, Wei-Yu
    Chen, Jin-Hsin
    Wu, Muzo
    Shih, Jin-Yuan
    Chen, Kuan-Yuh
    Ho, Chao-Chi
    Yang, James Chih-Hsin
    Yu, Chong-Jen
    CLINICAL LUNG CANCER, 2013, 14 (04) : 418 - 424
  • [22] Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease
    Kim, Hong Kwan
    Cho, Jong Ho
    Choi, Yong Soo
    Zo, Jae Ill
    Shim, Young Mog
    Park, Keunchil
    Ahn, Myung-Ju
    Ahn, Yong Chan
    Kim, Kwhanmien
    Kim, Jhingook
    LUNG CANCER, 2016, 96 : 56 - 62
  • [23] Postoperative radiotherapy in resected N2 non-small-cell lung cancer: Lung ART Comment
    Hendriks, Lizza E. L.
    De Ruysscher, Dirk K. M.
    LANCET ONCOLOGY, 2022, 23 (01): : 8 - 9
  • [24] NEW DIRECTIONS FOR CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER
    GREEN, MR
    CHEST, 1993, 103 (04) : S370 - S372
  • [25] Role of preoperative chemotherapy for non-small-cell lung cancer: A meta-analysis
    Nakamura, Haruhiko
    Kawasaki, Norihito
    Taguchi, Masahiko
    Kabasawa, Kazuyuki
    LUNG CANCER, 2006, 54 (03) : 325 - 329
  • [26] A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer
    Takamori, S
    Rikimaru, T
    Hayashi, A
    Tayama, K
    Mitsuoka, M
    Fujimoto, K
    Horiuchi, M
    Hayabuchi, N
    Oizumi, K
    Shirouzu, K
    LUNG CANCER, 2000, 29 (01) : 49 - 56
  • [27] Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspectiveaEuro
    Rocco, Gaetano
    Nason, Katie
    Brunelli, Alex
    Varela, Gonzalo
    Waddell, Thomas
    Jones, David R.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (04) : 1025 - 1027
  • [28] Predictors for Pathological N1 and N2 Disease in Clinical N1 Non-Small-Cell Lung Cancer
    Fukui, Takayuki
    Okasaka, Toshiki
    Kawaguchi, Koji
    Fukumoto, Koichi
    Nakamura, Shota
    Hakiri, Shuhei
    Ozeki, Naoki
    Yokoi, Kohei
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S589 - S589
  • [29] Afatinib and chemotherapy in non-small-cell lung cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2016, 17 (02): : E47 - E47
  • [30] Chemotherapy of evolved non-small-cell lung cancer
    Le Chevalier, T
    EUROCANCER 98, 1998, : 317 - 318
12345